Correlation Between Inhibrx and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Vincerx Pharma, you can compare the effects of market volatilities on Inhibrx and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Vincerx Pharma.
Diversification Opportunities for Inhibrx and Vincerx Pharma
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibrx and Vincerx is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Inhibrx i.e., Inhibrx and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Inhibrx and Vincerx Pharma
Given the investment horizon of 90 days Inhibrx is expected to generate 0.46 times more return on investment than Vincerx Pharma. However, Inhibrx is 2.19 times less risky than Vincerx Pharma. It trades about -0.01 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.2 per unit of risk. If you would invest 1,595 in Inhibrx on September 2, 2024 and sell it today you would lose (69.00) from holding Inhibrx or give up 4.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Vincerx Pharma
Performance |
Timeline |
Inhibrx |
Vincerx Pharma |
Inhibrx and Vincerx Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Vincerx Pharma
The main advantage of trading using opposite Inhibrx and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Vincerx Pharma vs. Tff Pharmaceuticals | Vincerx Pharma vs. Eliem Therapeutics | Vincerx Pharma vs. Inhibrx | Vincerx Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |